Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
847
+47
+6% +$5.77K ﹤0.01% 977
2026
Q1
$94.3K Buy
800
+42
+6% +$5.87K ﹤0.01% 998
2025
Q4
$124K Buy
758
+92
+14% +$14.4K ﹤0.01% 852
2025
Q3
$89K Buy
666
+97
+17% +$11.8K ﹤0.01% 917
2025
Q2
$70.8K Sell
569
-97
-15% -$12.3K ﹤0.01% 973
2025
Q1
$84.7K Buy
666
+332
+99% +$51.1K ﹤0.01% 836
2024
Q4
$48.1K Buy
334
+110
+49% +$15.8K ﹤0.01% 930
2024
Q3
$33.3K Buy
224
+130
+138% +$18.6K ﹤0.01% 1012
2024
Q2
$11.8K Sell
94
-16
-15% -$2.51K ﹤0.01% 1231
2024
Q1
$20.2K Buy
110
+13
+13% +$2.48K ﹤0.01% 1078
2023
Q4
$17.4K Sell
97
-75
-44% -$11.7K ﹤0.01% 1105
2023
Q3
$27.4K Sell
172
-22
-11% -$3.6K ﹤0.01% 991
2023
Q2
$27.4K Sell
194
-5
-3% -$802 ﹤0.01% 1003
2023
Q1
$33.5K Hold
199
﹤0.01% 944
2022
Q4
$34K Buy
199
+5
+3% +$907 ﹤0.01% 952
2022
Q3
$36K Sell
194
-22
-10% -$4.64K ﹤0.01% 950
2022
Q2
$35K Sell
216
-6
-3% -$949 ﹤0.01% 1006
2022
Q1
$42K Hold
222
﹤0.01% 1014
2021
Q4
$59K Buy
+222
New +$59.8K ﹤0.01% 948

Other funds holding RGEN

UMB Bank's RGEN Position: Q2 2026 in Review

UMB Bank increased its Repligen (RGEN) stake by 5.9% in Q2 2026, buying an estimated $5.77K and bringing the position to 847 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

UMB Bank first reported a position in RGEN in Q4 2021 and has held it in 19 quarters since. The position peaked at $124K in Q4 2025. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • UMB Bank held 847 shares of Repligen worth $116K as of Q2 2026.
  • UMB Bank bought 47 Repligen shares in Q2 2026, an estimated $5.77K.
  • Repligen made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #977 holding.
  • UMB Bank first reported a position in Repligen in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Repligen position peaked at $124K in Q4 2025.
  • 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.